Lincoln Park Capital is a private equity general partner firm headquartered in Chicago, IL, United States.
Onconova Therapeutics, a clinical-stage biopharmaceutical company, entered a $16m share purchase agreement with Lincoln Park Capital.
Lincoln Park Capital Fund has signed a stock purchase agreement with GelTech Solutions for up to $10m of common stock.
Greenwood Hall, a provider of technology-enabled student lifecycle management solutions, has secured an investment from Lincoln Park Capital
Read more news concerning Lincoln Park Capital
A sampling of Lincoln Park Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?